Presentations

Read the latest Presentations from Asarina Pharma, containing full details of Sepranolone, our first-in-class therapy for PMDD, our science, pipeline and business intelligence.

Meet our CEO Peter Nordkild, COO Karin Ekberg and CBO Otto Skolling as they present to investors in Stockholm, Gothenburg and online.

REDEYE: Asarina Pharma: CEO Peter Nordkild presents at Investor Forum Online Feb 25th

REDEYE: Asarina Pharma: Interview with CEO Peter Nordkild

REDEYE: Asarina Pharma: CEO Peter Norkild presents at Redeye Life Science Day 2020

REDEYE: Asarina Pharma: CEO Peter Nordkild presents at Neurology Seminar 2020

Archive

PDF:

Asarina Pharma TLR Presentation April 22, 2020 (pdf)
Asarina Pharma digital R&D Day presentation March 26, 2020 (pdf)
Asarina Pharma presentation at JPM in San Francisco January 2020 (pdf)
Asarina Pharma presentation at DnB in Oslo December 2019 (pdf)

VIDEO:

Watch our Presentation of Phase IIb PMDD study results here, April 2020

PETER NORDKILD, CEO, Börsveckans Småbolagsdag, Capital Markets Day, 2020

Press Kit

Access a range of resources on the Asarina Pharma team and offering.

The team

Management team
Scientific Advisory board

Company Logos

Image bank

Overview

Download brochure (English)
Download brochure (Swedish)